Table 5

Potency of melanocortin agonists at wild-type and mutant MC4 and MC3 receptors measured using cAMP accumulation

NDP-MSHα-MSHTHIQMTIIACTHHfRWKγ-MSHγtrp9
MC4R8.86 ± 0.07 (1.38)7.83 ± 0.06 (14.8)8.83 ± 0.15 (1.48)9.73 ± 0.05 (0.186)8.44 ± 0.09 (3.63)8.81 ± 0.03 (1.55)6.18 ± 0.19 (661)7.65 ± 0.12 (22.4)
D122A8.35 ± 0.14* (4.47)>1000 nM*** 7.31 ± 0.11**(49.0)N.D.N.D.N.D.N.D.N.D.
I125F8.57 ± 0.13 (2.69)7.77 ± 0.03 (17.0)8.04 ± 0.10*(9.12)9.33 ± 0.14* (0.468)N.D.7.95 ± 0.08*** (11.2)6.12 ± 0.12 (759)6.90 ± 0.25 (126)
I137T8.51 ± 0.15 (3.09)7.70 ± 0.05 (20.0)8.26 ± 0.16* (5.50)8.75 ± 0.29* (1.78)7.83 ± 0.12* (14.8)N.D.N.D.N.D.
F184M8.88 ± 0.18 (1.32)8.16 ± 0.14 (6.92)8.49 ± 0.09 (3.24)9.18 ± 0.20 (0.661)7.95 ± 0.25 (11.2)N.D.N.D.N.D.
F261A8.83 ± 0.14 (1.48)6.93 ± 0.14**(117)7.09 ± 0.14**(81.3)N.D.N.D.N.D.N.D.N.D.
F284A8.85 ± 0.10 (1.41)7.02 ± 0.01*** (95.5)7.57 ± 0.20** (26.9)9.19 ± 0.13* (0.646)7.11 ± 0.15** (77.6)N.D.N.D.N.D.
MC3R8.68 ± 0.10 (2.09)8.00 ± 0.07 (10.0)6.45 ± 0.22 (355)8.62 ± 0.01 (2.40)8.22 ± 0.05 (6.03)6.80 ± 0.05 (158)7.04 ± 0.14 (91.2)9.20 ± 0.15 (0.631)
F157I9.16 ± 0.21 (0.692)8.49 ± 0.08* (3.24)6.74 ± 0.14 (182)9.26 ± 0.18* (0.550)N.D.7.61 ± 0.18** (24.5)7.49 ± 0.11 (32.4)9.06 ± 0.03 (0.871)

Agonist-stimulation of cAMP accumulation was determined as described under Materials and Methods, and potency (EC50) values were determined. Potency values are expressed aspEC50 ± S.E.M (EC50 nM) (n= 3–6). The asterisk (*) indicates that D122A, I125F, I137T, F184M, F261A, or F284A exhibit a significantly different functional potency to the wild-type MC4 receptor or that F157I exhibits a significantly different functional potency to the wild-type MC3 receptor (*p < 0.05,**p < 0.01,***p < 0.005, Student's ttest).

  • N.D., not determined.